Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226596 · ClinicalTrials.gov registry record · NA
Non-Abstinence Outcomes in Methamphetamine Use Disorder
A NA study of Methamphetamine Use Disorder, sponsored by William Stoops.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07226596 is a NA study of Methamphetamine Use Disorder that is actively recruiting participants, run by William Stoops. The registered enrollment target is 300 participants, above the 30-participant average among 12 other Methamphetamine Use Disorder trials with a reported enrollment target (900% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07226596, a NA study of Methamphetamine Use Disorder, is actively recruiting participants, sponsored by William Stoops.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced methamphetamine use. These data will be used to change current accepted methamphetamine treatment endpoints and accelerate identification of therapies for methamphetamine use disorder.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
Study Locations (1)
Kentucky
- Psychopharmacology of Addiction Laboratory - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-01-14 |
| Est. Completion | 2031-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07226596
The ClinicalTrials.gov registry entry for NCT07226596 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 30-participant average among 12 other Methamphetamine Use Disorder trials with a reported enrollment target (900% higher). The listed sponsor is William Stoops, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methamphetamine Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.
NCT07226596 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT07226596 about?
NCT07226596 is a clinical study titled "Non-Abstinence Outcomes in Methamphetamine Use Disorder". Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating ...
What is the current status of trial NCT07226596?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-01-14. Estimated completion is 2031-01-04.
What conditions does trial NCT07226596 study?
This clinical trial studies the following conditions: Methamphetamine Use Disorder.
What interventions are being tested in trial NCT07226596?
The interventions under investigation include: Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT07226596?
This trial is sponsored by William Stoops, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07226596 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
RECRUITING · NA
-
Deep TMS of Neural Circuits Associated With Stimulant Use Disorder
RECRUITING · NA
-
A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder
RECRUITING · NA
-
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
RECRUITING · Phase 2
-
Methamphetamine and Troriluzole
RECRUITING · Early Phase 1
-
Methamphetamine Cue-reactivity
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.